Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2018-05-28
2019-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of Moisture Sensor Dressing Used for Exuding Wounds
NCT04890769
Evaluating Clinical Acceptance of a NPWT Wound Care System
NCT03670225
Clinical Investigation of Two Different Wound Dressings
NCT02904200
Evaluation of the Efficacy of an Antioxidant Dressing in Chronic Wound Healing
NCT03934671
Evaluation of Adhesion Properties in Wound Care Devices
NCT06392165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The overall aim was to observe the function of the sensor in clinical use and practical operation. Further the aim was to evaluate the two combinations of Absorbest Fuktsensor and DryMax Extra Soft and decide which combination would activate the sensor display in a satisfactory way related to the utilization of the dressings absorbing capacity while avoiding leakage and maceration.
The study was performed accordingly to ISO 14155 and the declaration of Helsinki.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A-B-A
Investigational device is Absorbest moisture sensor in variant A and variant B, placed on the backside of the wound dressing DryMax Extra Soft. Participants performed three dressing changes. They first received variant A, at next dressing change they received variant B, and on the third dressing change they received variant A again. No washout periods.
Sensor activation (on DryMax Extra Soft)
Study profile of sensor activation
B-A-B
Investigational device is Absorbest moisture sensor in variant A and variant B, placed on the backside of the wound dressing DryMax Extra Soft. Participants performed three dressing changes. They first received variant B, at next dressing change they received variant A, and on the third dressing change they received variant B again. No washout periods.
Sensor activation (on DryMax Extra Soft)
Study profile of sensor activation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sensor activation (on DryMax Extra Soft)
Study profile of sensor activation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Wound deemed suitable for treatment with study product
* Informed consent from the participants.
Exclusion Criteria
* Prisoner
* Bleeding from the wound
* Known allergy to components
* Wound infection
* Mental illness
* Illness or treatment of an indication other than the wound and which, according to the study personnel, can affect the wound treatment, the study and/or the dressing.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Linkoeping
OTHER
S2Clinic
OTHER
Absorbest AB
OTHER
Vinnova
OTHER_GOV
Swedish Energy Agency
OTHER
The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)
OTHER_GOV
Vårdcentralen Åby
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fredrik Iredahl
MD, PhD.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MD., PhD. Iredahl
Role: PRINCIPAL_INVESTIGATOR
Aby vardcentral, Region Ostergotland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hudkliniken, University hospital
Linköping, Region Östergötland, Sweden
S2Clinic
Linköping, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.